siRNA treatment decreases triglycerides in individuals with rare problem

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride degrees through 80% as well as decreased the threat of pancreatitis in people with relentless chylomicronemia, along with or even without a genetic prognosis.